Safety and Efficacy Study of Inhaled PUR003 on a Controlled Influenza Virus Challenge in Healthy Adult Subjects
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The objectives of the study are to demonstrate the effectiveness, safety and tolerability of
multiple daily doses of inhaled PUR003, in comparison with placebo, in healthy adults
experimentally inoculated with Influenza A/Wisconsin/67/2005 (H3N2) virus.
Phase:
Phase 1
Details
Lead Sponsor:
Pulmatrix Inc.
Collaborators:
Guys Drug Research Unit Quintiles, Inc. Retroscreen Virology Ltd.